SO
SGYP

STRS Ohio’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

STRS Ohio’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15,109
Closed -$68K – 1860
2013
Q3 		$68K Hold
15,109
– – ﹤0.01% 1693
2013
Q2 		$64K Buy
+15,109
New +$75.9K ﹤0.01% 1704

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

STRS Ohio's SGYP Position: Q4 2013 in Review

STRS Ohio sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2013, closing a stake of 15,109 shares — an estimated $68K sold.

STRS Ohio first reported a position in SGYP in Q2 2013 and held it in 2 quarters. The position peaked at $68K in Q3 2013. 72 funds tracked by Wall St. Rank hold SGYP as of Q4 2013.

  • STRS Ohio reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2013 after selling out during the quarter.
  • STRS Ohio sold 15,109 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2013, an estimated $68K.
  • STRS Ohio first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 2 quarters.
  • STRS Ohio's Synergy Pharmaceuticals, Inc Common Stock position peaked at $68K in Q3 2013.
  • 72 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2013.

Based on STRS Ohio's 13F filing for Q4 2013, filed 30 Jan 2014.